ベータ受容体アンタゴニストのパイプライン・インサイト2018

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMR2016136)
◆英語タイトル:Beta Receptor Antagonists -Pipeline Insights, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMR2016136
◆発行日:2019年04月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[ベータ受容体アンタゴニストのパイプライン・インサイト2018]についてメールでお問い合わせはこちら
本調査レポートでは、世界におけるベータ受容体アンタゴニストのパイプライン動向について調査・分析し、以下の構成でお届けいたします。

・ベータ受容体アンタゴニストの概要
・ベータ受容体アンタゴニストのパイプライン概要
・企業別開発中のベータ受容体アンタゴニスト
・後期治験段階の薬剤(Filed & Phase III):比較分析
・中期治験段階の薬剤(Phase II):比較分析
・初期治験段階の薬剤(Phase I & IND Filed):比較分析
・薬剤候補のプロファイル
・ベータ受容体アンタゴニストの評価
  - 単剤治療薬別評価
  - 併用治療薬別評価
  - 投与経路別評価
  - 分子種類別評価
・開発が中止された薬剤リスト
・開発休止中の薬剤リスト
・ベータ受容体アンタゴニスト開発に取り組んでいる企業リスト
・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s, “Beta Receptor Antagonists-Pipeline Insights, 2018”, report provides in depth insights on the pipeline drugs and their development activities around the Beta Receptor Antagonists. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Beta Receptor Antagonists. DelveInsight’s Report also assesses the Beta Receptor Antagonists therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.


Scope
• The report provides competitive pipeline landscape of Beta Receptor Antagonists
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Beta Receptor Antagonists pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Beta Receptor Antagonists and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Beta Receptor Antagonists Overview
• Beta Receptor Antagonists Disease Associated
• Beta Receptor Antagonists Pipeline Therapeutics
• Beta Receptor Antagonists Therapeutics under Development by Companies
• Beta Receptor Antagonists Filed and Phase III Products
• Comparative Analysis
• Beta Receptor Antagonists Phase II Products
• Comparative Analysis
• Beta Receptor Antagonists Phase I and IND Filed Products
• Comparative Analysis
• Beta Receptor Antagonists Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Beta Receptor Antagonists – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Beta Receptor Antagonists – Discontinued Products
• Beta Receptor Antagonists – Dormant Products
• Companies Involved in Therapeutics Development for Beta Receptor Antagonists
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Beta Receptor Antagonists by Therapy Area, 2018
• Number of Products under Development for Beta Receptor Antagonists, 2018
• Number of Products under Development by Companies
• Comparative Analysis by Filed and Phase III Products, 2018
• Comparative Analysis Phase II Products, 2018
• Comparative Analysis Phase I and IND Filed Products, 2018
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2018
• Drug Candidates Profiles
• Beta Receptor Antagonists Assessment by Monotherapy Products
• Beta Receptor Antagonists Assessment by Combination Products
• Beta Receptor Antagonists Assessment by Route of Administration
• Beta Receptor Antagonists Assessment by Stage and Route of Administration
• Beta Receptor Antagonists Assessment by Molecule Type
• Beta Receptor Antagonists Assessment by Stage and Molecule Type
• Beta Receptor Antagonists Therapeutics – Discontinued Products
• Beta Receptor Antagonists Therapeutics – Dormant Products
• Products under Development by Companies, 2018


List of Figures
• Number of Products under Development for Beta Receptor Antagonists by Therapy Area, 2018
• Number of Products under Development for Beta Receptor Antagonists, 2018
• Filed and Phase III Products, 2018
• Phase II Products, 2018
• Phase I and IND Filed Products, 2018
• Discovery and Pre-Clinical Stage Products, 2018
• Beta Receptor Antagonists Assessment by Monotherapy Products
• Beta Receptor Antagonists Assessment by Combination Products
• Beta Receptor Antagonists Assessment by Route of Administration
• Beta Receptor Antagonists Assessment by Stage and Route of Administration
• Beta Receptor Antagonists Assessment by Molecule Type
• Beta Receptor Antagonists Assessment by Stage and Molecule Type


*** レポートのキーワード ***

ベータ受容体アンタゴニスト、医薬品、製薬、研究開発、パイプライン、治療、治験

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界の天井取り付け式サプライビームシステム市場2016
    Notes:Production, means the output of Ceiling-mounted supply beam systems Revenue, means the sales value of Ceiling-mounted supply beam systems This report studies Ceiling-mounted supply beam systems in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focus …
  • 世界及び中国の防弾チョッキ市場2009-2019
    Market Research Report on Global and Chinese Bulletproof Vest Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Bulletproof Vest industry. The report firstly reviews the basic information of Bulletproof Vest including its classification, application and manufactu …
  • Database of Camera and Photographic Supplies Stores in Japan
    This company database includes the details of more than 100 camera and photographic supplies stores in Japan. The database contains the following information about the companies: Company name Contact details Contact persons Financial information Number of employees The database is designed for compa …
  • (株)ピーアール(PR:製造業)の企業概要・財務データ:韓国企業調査
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • 世界及び中国のLLDPE市場2017
    The 'Global and Chinese LLDPE Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global LLDPE industry with a focus on the Chinese market. The report provides key statistics on the market status of the LLDPE manufacturers and is a valuable so …
  • バイオ燃料の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Bio-fuel Revenue, means the sales value of Bio-fuel This report studies sales (consumption) of Bio-fuel in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and mar …
  • データセンターストレージの世界市場2018-2022
    About Data Center Storage A data storage system is responsible for storing business data or information for a specific period according to the needs of end-users. End-users make this data for their own use or make it public for specified purposes. Enterprises of individual users can fetch these data …
  • B.M.P. Pharma Trading AG (BMP):企業財務及びSWOT分析(医療業界)
    Summary This comprehensive SWOT profile of B.M.P. Pharma Trading AG provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • コロンビアのマットレス市場(~2020):市場規模、動向、予測
    The report Mattress Market in Colombia to 2020 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for mattresses in Colombia. The research includes historic data from 2009 to 2015 and forecasts until 2020 which makes …
  • 世界及び中国のマレイン酸ジメチル市場2018
    The 'Global and Chinese Dimethyl Maleate Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Dimethyl Maleate industry with a focus on the Chinese market. The report provides key statistics on the market status of the Dimethyl Maleate m …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMR2016136 )"ベータ受容体アンタゴニストのパイプライン・インサイト2018" (英文:Beta Receptor Antagonists -Pipeline Insights, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。